PNOYX | VIGIX | PNOYX / VIGIX | |
Total Expense Ratio | 0.62 | 0.04 | 1,550% |
Annual Report Gross Expense Ratio | 0.62 | 0.04 | 1,550% |
Fund Existence | 31 years | 27 years | - |
Gain YTD | 1.477 | 6.562 | 23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.37B | 294B | 2% |
Annual Yield % from dividends | 0.62 | 0.45 | 136% |
Returns for 1 year | -3.56 | 14.18 | -25% |
Returns for 3 years | 37.66 | 94.30 | 40% |
Returns for 5 years | 32.47 | 113.05 | 29% |
Returns for 10 years | 76.06 | 308.45 | 25% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CWIFX | 71.28 | 0.46 | +0.65% |
American Funds Capital World Gr&Inc 529F | |||
WCEAX | 18.43 | N/A | N/A |
Macquarie Core Equity Fund Class A | |||
ETAHX | 32.75 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
BLRAX | 11.71 | N/A | N/A |
Brookfield Global Listed Real Estate A | |||
RCMPX | 17.82 | N/A | N/A |
Lazard International Quality Gr R6 |